Related Experiment Video

Updated: Mar 29, 2026

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation
04:15

Author Spotlight: Development of a Method for Identifying Small Molecular Antagonists of β2 Integrin Activation

Published on: February 2, 2024

2.5K

β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer

Anne-Florence Blandin1, Guillaume Renner1, Maxime Lehmann1

  • 1Department "Tumoral Signaling and Therapeutic Targets," Faculty of Pharmacy, UMR7213 Centre National de la Recherche Scientifique, University of Strasbourg Illkirch, France.

Frontiers in Pharmacology
|December 5, 2015
PubMed

Insights

Integrins are cell adhesion molecules crucial for sensing the microenvironment. Their altered expression in cancer impacts tumor progression, making them key therapeutic targets, especially beta1 integrins.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Integrins are αβ heterodimeric transmembrane proteins functioning as adhesion molecules.
  • They mediate cell binding to the extracellular matrix and other cells, sensing the microenvironment.
  • Integrins regulate signaling pathways in response to extracellular matrix cues.

Purpose of the Study:

  • To summarize current knowledge on integrin roles in cancer hallmarks.
  • To focus on the implications of beta1 integrins in cancer progression.

Main Methods:

  • Literature review of integrin function in cancer.
  • Analysis of integrin expression modifications in tumor and associated cells.
  • Focus on beta1 integrin involvement in cancer hallmarks.

Main Results:

  • Integrin-mediated signaling is critically altered in tumoral settings.
  • Modified integrin expression in tumor and associated cells contributes to tumor initiation and progression.
  • Integrins are implicated in multiple cancer hallmarks.

Conclusions:

  • Integrins are vital sensors of the cellular microenvironment.
  • Alterations in integrin expression and function are key drivers of cancer.
  • Integrins, particularly beta1 integrins, represent promising therapeutic targets in oncology.
Keywords:
angiogenesishallmarks of cancerintegrinsmigrationinvasionproliferationresistance to cell deaththerapeutic target

More Related Videos

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies06:27

A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies

Published on: August 8, 2019

9.7K
CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells12:14

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells

Published on: June 2, 2022

3.2K

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
3.8K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.6K
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
6.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.4K